Toxikon's Webinars
Toxikon webinars are designed for professionals in research & development, quality assurance, regulatory affairs, and design engineering to gain knowledge relevant to safety assessments, as well as to stay up-to-date with relevant guidelines. Our webinar series is available at no cost to you and is accessible from your desktop computer. So sit back, relax and learn about all the latest industry trends for safety assessments.
Previous Webinars
Preclinical Testing for the Ocular Industry
Speaker: Gina Cantone, PhD., Study Director, Toxicology/Pharmacology & Technical Specialist for Ocular Services
Ocular devices and drugs, such as viscosurgical devices and pharmaceuticals for macular degeneration and glaucoma, have experienced an expansion in their respective industries. With increasing need for these products, the industry has come to rely even more on efficacy and safety assessments. This presentation provides a brief overview of the in-vivo, in-vitro, and analytical chemistry testing required to advance these products into clinical use.
Click here to download this Webinar
Date: October 21, 2009
Time: 3:00 p.m. EST
In Vitro Biocompatibility Testing: Safety Assurance for Complex Medical Devices
Speaker: Franck Grall, Ph.D., Study Director, Toxikon Corporation
In the last several years, newly developed medical devices, such as atherectomy devices and embolization coils, have become increasingly more complex. As a result, the development of in vitro testing for cytoxicity and hemocompatibility has had to quickly adapt to accommodate the testing needs of these multifaceted devices. This presentation will provide a brief overview of biocompatibility assays for cytoxicity and hemocompatibility assays per ISO 10993 guidelines.
Click here to download this Webinar
Date: March 26, 2009
Time: 2:30 p.m. EST
Implications of the Update to ISO 10993-10: Testing for Irritation and Sensitization
Speaker: Laurence Lister, Director of Biocompatibility Services, Toxikon Corporation
ISO 10993-10, the guidance document for irritation and delayed-type hypersensitivity testing, is currently in the revision process. Voting terminates January 7, 2009, and with it changes to some test methods will have to be made. Laurence Lister has step-wise compared the draft version to the current version and will discuss key points of contrast and comparison. There are some substantial changes suggested in this document that could render current testing methods non-compliant with future testing guidelines. Will you be ready for the changes if this is implemented?
Date : December 10, 2008
Time : 4:00pm EST
The Use of Extractable Testing for Qualification of Disposable Components and Systems
Speaker: Stephen Doherty, Ph.D.-Extractables & Leachables Program Director, Toxikon Corporation
A strategy for the implementation of disposables in bioprocessing and/or material storage must consider extractable/leachable testing as part of the overall material/component qualification. Disposable components with the potential to contribute contaminants to the final product include tubing, gaskets, containers, filters, closures, etc. A properly designed program will allow for the evaluation of various component types using a comprehensive analytical approach to understand the material(s) and their interactions. Strategies for the design and execution of a qualification program will be discussed to allow for the full advantages of disposables to be realized, while minimizing potential downstream contamination.
Date : November 13, 2008
Time : 2:00pm EST
For additional details on our webinar series, please contact:
Joann Hoxha
Phone: (800) 458-4141
Email Address: Joann.Hoxha@toxikon.com
|
